Newsfeed

Portuguese cultivators have welcomed moves by the country’s police to crack down on a criminal gang using loopholes in its medical cannabis laws to cultivate and illegally export around £15m of product.

Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European… Read more: Pharmaceutical Cannabis Steps Into the Spotlight as DanCann, Phytanix and Sandoz Unveil Major Moves

One of the key differences between medical cannabis and other more traditional treatments is the highly personalised nature of how each patient is affected.

Malta’s government has passed a string of controversial new regulations imposing stricter controls on cannabis users and associations, causing uproar from… Read more: Smell That? Malta’s New Cannabis Crackdown Could Cost You €235

With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success. 

The Business of Cannabis Awards 2025, taking place on Tuesday, 24 June 2025 in London, celebrate the very best across the… Read more: How to Win a Business of Cannabis Award in 2025: What the Judges Are Really Looking For

David Sergi and Kyler Rucker of Sergi and Associates, a San Marcos-based law firm Across the state, lawful hemp retailers are… Read more: The Hemp Trap: How Texas Cops and A Crime Lab Criminalize the Legal Cannabis Industry for Profit

Over the last decade, the European medical cannabis landscape has seen a significant surge of new products entering the market, providing patients, especially in the UK and Germany, with a greater variety than ever before. 

Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector. 

The US legal cannabis industry is in a transitional phase, according to a new report, which showed jobs falling despite revenue increasing. 

Oxford Cannabinoid Technologies Holdings, one of the UK’s few remaining pharmaceutical cannabis companies, appears to have entered administration. 

A number of countries in Europe are currently at some stage of medical cannabis reform. These reforms are set to lay the foundation for five permanent medical cannabis markets in the region.

From May 22 to 24, 2025, São Paulo will host the 4th edition of the Medical Cannabis Fair and the Brazilian Congress on Medicinal Cannabis. These simultaneous events serve as key platforms for discussing scientific, regulatory, and economic developments in Brazil’s cannabis industry.

New York State’s cannabis industry is facing renewed turmoil as budget changes, industry backlash, and a major product investigation converge to… Read more: New York Cannabis Regulation Under Fire Amid Budget Cuts, Industry Clashes, and Product Investigations

Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification for Europe’s First Handheld Liquid Inhalation Device 

As the cannabis industry continues to mature across Europe and beyond, the need to recognise true excellence has never been greater. With entries now open for the Business of Cannabis Awards 2025, companies have a unique opportunity to demonstrate leadership, validate their impact, and strengthen their reputation within the sector.

Accounts receivable (AR) are ballooning to unsustainable levels, and beyond a few informal “blacklisted” groups on social media, no one is talking about the financial chokehold this is putting on the supply chain.

California’s embattled legal cannabis industry is facing a significant spike in taxation in the coming weeks, but efforts are underway to block the potentially ruinous bill before it is enforced. 

Prohibition Partners and Mary Jane Berlin are pleased to announce the full speaker line-up and agenda for the inaugural International Cannabis Business Day, taking place on Thursday, June 19, 2025, at Messe Berlin. 

Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’. 

We have delved into some of the key data and insights set to be integrated into the new site, providing a taste of what readers can expect. For further exclusive analysis into the European cannabis market, pre-orders for data packages are available now. 

We are pleased to announce that entries are now open for the Business of Cannabis Awards 2025 — the leading event recognising excellence across Europe’s cannabis sector.

DeFloria, a joint venture between Charlotte’s Web Holdings and Ajna BioSciences, is advancing toward the start of its Phase 2 clinical trial for AJA001, a cannabinoid-based (FDA) botanical drug developed to treat behavioral symptoms associated with autism spectrum disorder (ASD).

Arizona’s hemp industry this week received a welcome reprieve from an overnight ban on all ‘consumable hemp products’, as the Court of Appeals agreed to consider a collaborative pushback from the industry. 

Former hemp farmers are switching to corn, and larger players are leaving Italy altogether as its once-thriving hemp and CBD industry is battered by the hard-line government.

When Maryland Gov. Wes Moore signed a law on April 22 exempting employee stock ownership plans (ESOPs) from the state’s strict five-year license-hold requirement for cannabis businesses, he opened up an exit strategy for founders.

Cannabis rescheduling was thrown back into the spotlight last week as the new potential head of the Drug Enforcement Administration (DEA) said it would be a ‘priority’. 

THE latest move by the French authorities to undermine the country’s thriving CBD industry will be met with widespread resistance, say… Read more: French CBD Industry Under Attack From Food Regulators

Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education. 

THE central European nation of Slovenia is developing proposals which could establish a continental benchmark for medical cannabis. Governing coalition members… Read more: Slovenia Breaks Cannabis Mould, Latvia to Follow Suit, Bavaria Turns Green, Record Portuguese Exports…And More

As the medical cannabis sector matures, patient feedback is playing an increasingly important role in shaping market dynamics and building trust when it comes to choosing the right clinic.

Intoxicating hemp product sellers in Arizona could now face criminal charges, raids and fines as a Country Court Judge ruled to dismiss a temporary restraining order from industry representatives. 

Israel’s cannabis industry is engaged in a heated and divisive showdown as a proposed 165% tax on Canadian cannabis imports, on which a large portion of the industry and many patients rely, hangs in the balance. 

Tilray    The international cannabis giant has announced plans to issue a ‘reverse stock split’, an increasingly common tool in the… Read more: Tilray & Flora Growth Target Stock Consolidation as Values Continue Decline, Chill Brands Raises £1m From Major Shareholder

A coalition of pro-cannabis medical professionals has dropped its lawsuit against the Drug Enforcement Administration (DEA), clearing one of the many hurdles preventing the process from progressing. 

Two separate bipartisan cannabis reform bills that, if passed, would transform US cannabis regulation across the country. 

CB21 Pharma, a leading pharmaceutical company focused on developing and marketing innovative cannabinoid-based treatments, is pleased to announce the successful completion… Read more: CB21 Pharma Successfully Passes Certification Audit for Dronabinol Manufacturing

Having done the legwork over the last five years to build a state-of-the-art 30,000sq ft indoor growing facility, and secure licencing to cultivate, manufacture and supply medical cannabis flower from its facility, Dalgety is wasting no time in ramping up its operations. 

The largest meta-analysis of scientific data on medical cannabis’ viability in cancer treatment to date has been published, finding overwhelmingly positive… Read more: Meta-Analysis Results Should ‘Redefine the Consensus Around Cannabis as a Medical Intervention’ for Cancer

Italy’s hemp industry has been dealt another major blow this week as the Regional Administrative Court (TAR) rejected an appeal, rendering CBD oil a narcotic.

New Hampshire’s Senate Judiciary Committee has voted to recommend against a bipartisan bill to legalize possession of cannabis for adults, but there is still hope for the bill in a full Senate floor vote. 

Ananda Pharma    Just days after welcoming the former Chief Operating Officer of GW and Jazz Pharmaceuticals to its ranks Ananda… Read more: Ananda Lists on US OTCQB Market, Argent Bio Signs Data Sharing Deal With AusCann, & IMC Under New Threat of NASDAQ Delisting

In a press release published on 9 April, the Académie de Médecine (French Academy of Medicine) reiterated its prohibitionist stance on cannabis, citing a select range of public health concerns and international studies to support its position while consciously omitting the harm caused by prohibition.

The CEO Mammoth Farms stumbled onto ‘the blueprint for how to launder marijuana’ in and out of the state’s regulated industry, he told MJBizDaily.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the Food Standards Agency (FSA) have both issued regulatory updates on CBD this week. 

Florida Governor Ron Desantis and his wife are coming under increasing scrutiny over their apparent use of millions in public settlement funds to bankroll a critical anti-cannabis legalization campaign. 

The US Cannabis Roundtable (USCR), one of the most influential advocacy groups in the country, is ‘still optimistic about the President acting on cannabis reform’. 

Mamedica has today announced an exclusive partnership with Cookies to offer its premium pharmaceutical products to patients across the UK.

Israel has seemingly followed in the footsteps of its US ally this week after announcing plans to impose 165% tariffs on cannabis imports from Canada. 

From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.